# Yixuan Biology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yixuan-biology

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Angel (Aug 19, 2025)
- Investors on record: 3

## About

Founded in 2025 and based in Shanghai, China, Yixuan Biology is a biochemical product developer, primarily engaged in biochemical product technology R&D, medical research, and experimental development, dedicated to meeting market demand. Yixuan Biology's founding team comprises numerous industry experts, and its R&D team boasts extensive international experience. In August 2025, Yixuan Biology closed an Angel funding co-led by new investors FIRHealth Capital and Frees Fund, with participation from new investor Yongkan Investment.

The company focuses on the development of novel nucleic acid-based therapeutics. Through its unique precision delivery technology, it transcends the limitations of traditional drug therapies and provides revolutionary solutions for chronic and aging diseases.

The company generates revenue by doing medical research and experimental development and selling biochemical products.

The funding raised in August 2025 will be primarily used to accelerate the global development of leading pan-nucleic acid drugs, aiming to develop breakthrough therapies for chronic diseases and aging-related diseases, and lay a solid foundation for Yixuan Biology's continued innovation and global expansion.

## Funding rounds

- Angel, Aug 19, 2025 — Yongkan Investment, Frees Fund, FIRHealth Capital

## Investors

- Yongkan Investment (https://capitalatlas.ai/funds/yongkan-investment) — Angel
- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Angel
- FIRHealth Capital (https://capitalatlas.ai/funds/firhealth-capital) — Angel